Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Klein

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Cancer|April 26, 2026
Neoadjuvant chemotherapy for soft-tissue sarcoma of the extremities: A post-hoc Sarculator-based risk analysis of the EORTC 62961-ESHO 95 randomized trialMarkus Albertsmeier, Valeria Milani, Lars H Lindner, et al.
Cancer Medicine|February 26, 2025
Doxorubicin Plus Dacarbazine Versus Doxorubicin Plus Ifosfamide in Combination With Regional Hyperthermia in Patients With Advanced Leiomyosarcoma: A Propensity Score-Matched AnalysisLuc M Berclaz, Vindi Jurinovic, Anton Burkhard-Meier, et al.
Clinical & Experimental Metastasis|February 29, 2024
Differentiation of benign and metastatic lymph nodes in soft tissue sarcomaAnton Burkhard-Meier, Vindi Jurinovic, Luc M Berclaz, et al.
Journal of Cancer Research and Clinical Oncology|April 26, 2025
First-line pazopanib in patients with metastatic epithelioid hemangioendothelioma: a retrospective single-center analysisAnton Burkhard-Meier, Vera Valerie Rechenauer, Vindi Jurinovic, et al.
Acta Oncologica (Stockholm, Sweden)|January 15, 2025
Maintenance treatment with trofosfamide in patients with advanced soft tissue sarcoma - a retrospective single-centre analysisAnton Burkhard-Meier, Vera Valerie Rechenauer, Luc M Berclaz, et al.
Journal of Cancer Research and Clinical Oncology|January 8, 2026
Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: a machine learning analysisMichael Hoberger, Romy L Zuber, Anton Burkhard-Meier, et al.
Oncology and Therapy|June 5, 2026
Machine Learning-Guided Survival Prediction and Treatment Sequencing in Advanced Soft Tissue Sarcoma Beyond Second-Line Therapy: A Retrospective Cohort StudyMichael Hoberger, Dorit Di Gioia, Romy L Zuber, et al.
Science Translational Medicine|September 9, 2016
Heat shock protein-based therapy as a potential candidate for treating the sphingolipidosesThomas Kirkegaard, James Gray, David A Priestman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 13, 2024
Unraveling the role of local ablative therapies for patients with metastatic soft tissue sarcoma - A retrospective multicenter study of the Bavarian university hospitalsAnton Burkhard-Meier, Matthias Grube, Vindi Jurinovic, et al.
Annals of Surgical Oncology|May 14, 2025
Does Size Outweigh Number in Predicting Survival After Pulmonary Metastasectomy for Soft Tissue Sarcoma? Insights from a Retrospective Multicenter StudyAnton Burkhard-Meier, Matthias Grube, Vindi Jurinovic, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Cancer|April 26, 2026
Neoadjuvant chemotherapy for soft-tissue sarcoma of the extremities: A post-hoc Sarculator-based risk analysis of the EORTC 62961-ESHO 95 randomized trialMarkus Albertsmeier, Valeria Milani, Lars H Lindner, et al.
Cancer Medicine|February 26, 2025
Doxorubicin Plus Dacarbazine Versus Doxorubicin Plus Ifosfamide in Combination With Regional Hyperthermia in Patients With Advanced Leiomyosarcoma: A Propensity Score-Matched AnalysisLuc M Berclaz, Vindi Jurinovic, Anton Burkhard-Meier, et al.
Clinical & Experimental Metastasis|February 29, 2024
Differentiation of benign and metastatic lymph nodes in soft tissue sarcomaAnton Burkhard-Meier, Vindi Jurinovic, Luc M Berclaz, et al.
Journal of Cancer Research and Clinical Oncology|April 26, 2025
First-line pazopanib in patients with metastatic epithelioid hemangioendothelioma: a retrospective single-center analysisAnton Burkhard-Meier, Vera Valerie Rechenauer, Vindi Jurinovic, et al.
Acta Oncologica (Stockholm, Sweden)|January 15, 2025
Maintenance treatment with trofosfamide in patients with advanced soft tissue sarcoma - a retrospective single-centre analysisAnton Burkhard-Meier, Vera Valerie Rechenauer, Luc M Berclaz, et al.
Journal of Cancer Research and Clinical Oncology|January 8, 2026
Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: a machine learning analysisMichael Hoberger, Romy L Zuber, Anton Burkhard-Meier, et al.
Oncology and Therapy|June 5, 2026
Machine Learning-Guided Survival Prediction and Treatment Sequencing in Advanced Soft Tissue Sarcoma Beyond Second-Line Therapy: A Retrospective Cohort StudyMichael Hoberger, Dorit Di Gioia, Romy L Zuber, et al.
Science Translational Medicine|September 9, 2016
Heat shock protein-based therapy as a potential candidate for treating the sphingolipidosesThomas Kirkegaard, James Gray, David A Priestman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 13, 2024
Unraveling the role of local ablative therapies for patients with metastatic soft tissue sarcoma - A retrospective multicenter study of the Bavarian university hospitalsAnton Burkhard-Meier, Matthias Grube, Vindi Jurinovic, et al.
Annals of Surgical Oncology|May 14, 2025
Does Size Outweigh Number in Predicting Survival After Pulmonary Metastasectomy for Soft Tissue Sarcoma? Insights from a Retrospective Multicenter StudyAnton Burkhard-Meier, Matthias Grube, Vindi Jurinovic, et al.
Pageof 11